An Open-label, Parallel Drug Interaction Study to Evaluate the Effect of a CYP3A Moderate Inducer Efavirenz on the Pharmacokinetics of Quizartinib in Healthy Subjects

Name: An Open-label, Parallel Drug Interaction Study to Evaluate the Effect of a CYP3A Moderate Inducer Efavirenz on the Pharmacokinetics of Quizartinib in Healthy Subjects
Creator: Vivli
Published: 2025-04-23 20:26:14
License: 暂无描述

DataCite Commons2025-04-23 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/PR00011321/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

This drug-drug interaction (DDI) study has been designed to investigate the effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of quizartinib and its major circulating active metabolite AC886.

提供机构：

Vivli

创建时间：

2025-04-23